2012 Annual Meeting | White Matter Disease in Cognitive Aging

Date Sunday 04/22/12

Time 02:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Charles S. DeCarli, MD, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the prevalence of white matter disease in the general population of cognitively normal older adults; learn of the consequences of white matter disease on incident cognitive impairment, stroke and death; and learn of the biological mechanisms whereby white matter disease affects cognition and treatment options currently available to reduce the impact of white matter disease on general and cognitive health.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Tracks Subspecialty in Focus

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic, Interactive

Program Evaluations

Event Timeline
02:00 PM - 02:15 PM		Introduction Charles S. DeCarli, MD, FAAN
02:00 PM - 06:00 PM
02:15 PM - 03:00 PM		Prevalence and Associated Risk Factors Sudha Seshadri, MD, FAAN
03:00 PM - 03:45 PM		Impact on Dementia, Disability, Stroke, and Mortality Clinton B. Wright, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:45 PM		Cognitive Aging and White Matter Disease Charles S. DeCarli, MD, FAAN
04:45 PM - 05:30 PM		Outcome After Treatment of Vascular Risk Factors Carole Dufouil, PhD
05:30 PM - 06:00 PM		Discussion

Faculty Disclosures
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Clinton B. Wright, MD, FAAN	An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MARSHALL DENNEHY. The institution of an immediate family member of Dr. Wright has received research support from Oncospace. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Carole Dufouil, PhD	No disclosure on file

��ɫ��

��ɫ��